193 related articles for article (PubMed ID: 33751366)
1. TRIPODD: a Novel Fluorescence Imaging Platform for In Situ Quantification of Drug Distribution and Therapeutic Response.
McMahon NP; Solanki A; Wang LG; Montaño AR; Jones JA; Samkoe KS; Tichauer KM; Gibbs SL
Mol Imaging Biol; 2021 Oct; 23(5):650-664. PubMed ID: 33751366
[TBL] [Abstract][Full Text] [Related]
2.
McMahon NP; Solanki A; Wang LG; Montaño AR; Jones JA; Samkoe KS; Tichauer KM; Gibbs SL
Theranostics; 2024; 14(7):2816-2834. PubMed ID: 38773974
[No Abstract] [Full Text] [Related]
3. Fluorescent Imaging for
McMahon NP; Solanki A; Jones J; Kwon S; Chang YH; Chin K; Nederlof MA; Gray JW; Gibbs SL
Proc SPIE Int Soc Opt Eng; 2020 Feb; 11219():. PubMed ID: 32296256
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive quantification of target availability during therapy using paired-agent fluorescence tomography.
Meng B; Folaron MR; Strawbridge RR; Sadeghipour N; Samkoe KS; Tichauer K; Davis SC
Theranostics; 2020; 10(24):11230-11243. PubMed ID: 33042280
[TBL] [Abstract][Full Text] [Related]
5. Oligonucleotide conjugated antibodies permit highly multiplexed immunofluorescence for future use in clinical histopathology.
McMahon NP; Jones JA; Kwon S; Chin K; Nederlof MA; Gray JW; Gibbs SL
J Biomed Opt; 2020 May; 25(5):1-18. PubMed ID: 32445299
[TBL] [Abstract][Full Text] [Related]
6. Paired Agent Fluorescence Imaging of Cancer in a Living Mouse Using Preassembled Squaraine Molecular Probes with Emission Wavelengths of 690 and 830 nm.
Schreiber CL; Zhai C; Dempsey JM; McGarraugh HH; Matthews BP; Christmann CR; Smith BD
Bioconjug Chem; 2020 Feb; 31(2):214-223. PubMed ID: 31756298
[TBL] [Abstract][Full Text] [Related]
7. Intracellular paired agent imaging enables improved evaluation of tyrosine kinase inhibitor target engagement.
Solanki A; Wang L; Korber J; McMahon N; Tichauer K; Samkoe KS; Gibbs SL
Proc SPIE Int Soc Opt Eng; 2020 Feb; 11219():. PubMed ID: 32292225
[TBL] [Abstract][Full Text] [Related]
8. Oligonucleotide conjugated antibody strategies for cyclic immunostaining.
Jones JA; McMahon NP; Zheng T; Eng J; Chin K; Kwon S; Nederlof MA; Gray JW; Gibbs SL
Sci Rep; 2021 Dec; 11(1):23844. PubMed ID: 34903759
[TBL] [Abstract][Full Text] [Related]
9. Accelerating precision anti-cancer therapy by time-lapse and label-free 3D tumor slice culture platform.
Xing F; Liu YC; Huang S; Lyu X; Su SM; Chan UI; Wu PC; Yan Y; Ai N; Li J; Zhao M; Rajendran BK; Liu J; Shao F; Sun H; Choi TK; Zhu W; Luo G; Liu S; Xu L; Chan KL; Zhao Q; Miao K; Luo KQ; Ge W; Xu X; Wang G; Liu TM; Deng CX
Theranostics; 2021; 11(19):9415-9430. PubMed ID: 34646378
[TBL] [Abstract][Full Text] [Related]
10. Facilitating in vivo tumor localization by principal component analysis based on dynamic fluorescence molecular imaging.
Gao Y; Chen M; Wu J; Zhou Y; Cai C; Wang D; Luo J
J Biomed Opt; 2017 Sep; 22(9):1-9. PubMed ID: 28929642
[TBL] [Abstract][Full Text] [Related]
11. Molecular Imaging of P-glycoprotein in Chemoresistant Tumors Using a Dual-Modality PET/Fluorescence Probe.
Wang M; Mao C; Wang H; Ling X; Wu Z; Li Z; Ming X
Mol Pharm; 2017 Oct; 14(10):3391-3398. PubMed ID: 28813596
[TBL] [Abstract][Full Text] [Related]
12. NIR-Cyanine Dye Linker: a Promising Candidate for Isochronic Fluorescence Imaging in Molecular Cancer Diagnostics and Therapy Monitoring.
Komljenovic D; Wiessler M; Waldeck W; Ehemann V; Pipkorn R; Schrenk HH; Debus J; Braun K
Theranostics; 2016; 6(1):131-41. PubMed ID: 26722379
[TBL] [Abstract][Full Text] [Related]
13. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
[TBL] [Abstract][Full Text] [Related]
14. Flexible Cyclic Immunofluorescence (cyCIF) Using Oligonucleotide Barcoded Antibodies.
McMahon NP; Jones JA; Anderson AN; Dietz MS; Wong MH; Gibbs SL
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765785
[TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast enhanced fluorescent molecular imaging of vascular disruption induced by combretastatin-A4P in tumor xenografts.
Liu L; Su X; Mason RP
J Biomed Nanotechnol; 2014 Aug; 10(8):1545-51. PubMed ID: 25016654
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence and Bioluminescence Imaging of Orthotopic Brain Tumors in Mice.
McKinnon E; Moore A; Dixit S; Zhu Y; Broome AM
Methods Mol Biol; 2017; 1530():283-305. PubMed ID: 28150209
[TBL] [Abstract][Full Text] [Related]
17. Mitochondria targeting and near-infrared fluorescence imaging of a novel heptamethine cyanine anticancer agent.
Ning J; Huang B; Wei Z; Li W; Zheng H; Ma L; Xing Z; Niu H; Huang W
Mol Med Rep; 2017 Jun; 15(6):3761-3766. PubMed ID: 28440435
[TBL] [Abstract][Full Text] [Related]
18. Core-shell polymeric nanoparticles co-loaded with photosensitizer and organic dye for photodynamic therapy guided by fluorescence imaging in near and short-wave infrared spectral regions.
Chepurna OM; Yakovliev A; Ziniuk R; Nikolaeva OA; Levchenko SM; Xu H; Losytskyy MY; Bricks JL; Slominskii YL; Vretik LO; Qu J; Ohulchanskyy TY
J Nanobiotechnology; 2020 Jan; 18(1):19. PubMed ID: 31973717
[TBL] [Abstract][Full Text] [Related]
19. Highly Homogeneous Biotinylated Carbon Nanodots: Red-Emitting Nanoheaters as Theranostic Agents toward Precision Cancer Medicine.
Scialabba C; Sciortino A; Messina F; Buscarino G; Cannas M; Roscigno G; Condorelli G; Cavallaro G; Giammona G; Mauro N
ACS Appl Mater Interfaces; 2019 Jun; 11(22):19854-19866. PubMed ID: 31088077
[TBL] [Abstract][Full Text] [Related]
20. Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging.
Hekman MCH; Boerman OC; Bos DL; Massuger LFAG; Weil S; Grasso L; Rybinski KA; Oosterwijk E; Mulders PFA; Rijpkema M
Mol Pharm; 2017 Oct; 14(10):3457-3463. PubMed ID: 28826214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
